Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS · Delayed Price · Currency is USD
0.0048
+0.0009 (23.08%)
Mar 6, 2026, 3:56 PM EST
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $2.12 million as of March 6, 2026. Its market cap has increased by 680.00% in one year.
Market Cap
2.12M
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 2.12M, a decrease of -98.12%. That is a compound annual growth rate of -21.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.12M | 50.00% |
| Dec 31, 2025 | 1.41M | 420.00% |
| Dec 31, 2024 | 271.86K | -99.60% |
| Dec 29, 2023 | 67.15M | -83.68% |
| Dec 30, 2022 | 411.38M | -71.18% |
| Dec 31, 2021 | 1.43B | -18.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 1.29M |
| Vaxxinity | 1.27M |
| Halberd | 1.23M |
| Evofem Biosciences | 1.15M |
| CERo Therapeutics Holdings | 1.14M |
| International Stem Cell | 1.13M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.02M |